IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

STAAR SURGICAL CO (STAA)

Ophthalmic Goods

Latest Price
$22.45
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
7.29
P/B Ratio
3.08

Valuation metrics

adjust assumptions →
Norm. op. income: $20M (median of 6yr)
Tax rate: 22%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$6.96
69% downside
Base FCF: $24M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$12.07
46% downside

Institutional Ownership

100.0% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BROADWOOD CAPITAL INC16.12M$462.0M32.17%--2026-06-30
BlackRock, Inc.6.73M$193.0M13.43%+65.0K2026-06-30
Madison Avenue Partners, LP4.18M$119.0M8.33%+1.73M2026-06-30
Yunqi Capital Ltd3.26M$93.0M6.50%--2026-06-30
Point72 Asset Management, L.P.2.44M$69.0M4.86%+1.61M2026-06-30
GOLDMAN SACHS GROUP INC2.15M$61.0M4.29%+1.08M2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC1.98M$56.0M3.95%-144.0K2026-06-30
STATE STREET CORP1.77M$50.0M3.53%-63.6K2026-06-30
Anatole Investment Management Ltd1.65M$47.0M3.30%+50.0K2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC1.55M$44.0M3.10%-137.9K2026-06-30
View all institutional holders →